Dimittri Delevry

460 total citations
22 papers, 269 citations indexed

About

Dimittri Delevry is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Dimittri Delevry has authored 22 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Dermatology, 14 papers in Immunology and Allergy and 7 papers in Physiology. Recurrent topics in Dimittri Delevry's work include Dermatology and Skin Diseases (17 papers), Allergic Rhinitis and Sensitization (11 papers) and Asthma and respiratory diseases (7 papers). Dimittri Delevry is often cited by papers focused on Dermatology and Skin Diseases (17 papers), Allergic Rhinitis and Sensitization (11 papers) and Asthma and respiratory diseases (7 papers). Dimittri Delevry collaborates with scholars based in United States, France and Germany. Dimittri Delevry's co-authors include Quang A. Le, Eric L. Simpson, Ashish Bansal, Chien‐Chia Chuang, Isabelle Guillemin, Abhijit Gadkari, John T. O’Malley, Ana B. Rossi, Zhen Chen and John Browning and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, The Journal of Pediatrics and Journal of the American Academy of Dermatology.

In The Last Decade

Dimittri Delevry

20 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dimittri Delevry United States	9	181	140	81	40	21	22	269
Peter Maisel Germany	5	199 1.1×	82 0.6×	47 0.6×	116 2.9×	17 0.8×	13	265
Inbar Zucker Israel	3	316 1.7×	139 1.0×	54 0.7×	100 2.5×	62 3.0×	4	365
S. Steinke Germany	11	227 1.3×	137 1.0×	79 1.0×	92 2.3×	38 1.8×	21	274
Claudia Riepe Germany	8	252 1.4×	108 0.8×	79 1.0×	102 2.5×	33 1.6×	12	299
Stéphanie Mérhand France	8	192 1.1×	135 1.0×	62 0.8×	27 0.7×	14 0.7×	25	214
Lawson United Kingdom	4	297 1.6×	219 1.6×	121 1.5×	13 0.3×	28 1.3×	6	388
M. Wittenmeier Germany	6	414 2.3×	328 2.3×	161 2.0×	46 1.1×	27 1.3×	6	458
Lin Xi China	8	67 0.4×	161 1.1×	148 1.8×	5 0.1×	9 0.4×	26	220
Whitney Block United States	10	89 0.5×	385 2.8×	183 2.3×	15 0.4×	52 2.5×	13	461
S. Scheewe Germany	10	466 2.6×	373 2.7×	189 2.3×	47 1.2×	32 1.5×	20	554

Countries citing papers authored by Dimittri Delevry

Since Specialization

Citations

This map shows the geographic impact of Dimittri Delevry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimittri Delevry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimittri Delevry more than expected).

Fields of papers citing papers by Dimittri Delevry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimittri Delevry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimittri Delevry. The network helps show where Dimittri Delevry may publish in the future.

Co-authorship network of co-authors of Dimittri Delevry

This figure shows the co-authorship network connecting the top 25 collaborators of Dimittri Delevry. A scholar is included among the top collaborators of Dimittri Delevry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimittri Delevry. Dimittri Delevry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simpson, Eric L., Jonathan I. Silverberg, Margitta Worm, et al.. (2024). Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology. 90(6). 1190–1199. 21 indexed citations

Kimball, Alexa B., Dimittri Delevry, Min Yang, et al.. (2023). Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study. Dermatology and Therapy. 13(9). 2107–2120. 11 indexed citations

Weidinger, Stephan, Eric L. Simpson, Jonathan I. Silverberg, et al.. (2023). Burden of atopic dermatitis in paediatric patients: an international cross-sectional study. British Journal of Dermatology. 190(6). 846–857. 15 indexed citations

Barbarot, S., Abhijit Gadkari, Eric L. Simpson, et al.. (2022). The Family Impact of Atopic Dermatitis in the Pediatric Population: Results from an International Cross-sectional Study. The Journal of Pediatrics. 246. 220–226.e5. 30 indexed citations

Eichenfield, Lawrence F., April W. Armstrong, Emma Guttman‐Yassky, et al.. (2022). Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset. Dermatology and Therapy. 12(6). 1337–1350. 6 indexed citations

Blauvelt, Andrew, Emma Guttman‐Yassky, Amy S. Paller, et al.. (2022). Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE). American Journal of Clinical Dermatology. 23(3). 365–383. 62 indexed citations

Paller, Amy S., Gil Yosipovitch, Stephan Weidinger, et al.. (2022). Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis. Dermatology and Therapy. 12(12). 2839–2850. 4 indexed citations

Delevry, Dimittri, Jingdong Chao, & Chien‐Chia Chuang. (2022). 32929 Dupilumab decreases concomitant therapy use in adults with atopic dermatitis (AD): Long-term data from the RELIEVE-AD study. Journal of the American Academy of Dermatology. 87(3). AB45–AB45. 1 indexed citations

Strober, Bruce, Jingdong Chao, Chien‐Chia Chuang, et al.. (2022). 33322 Dupilumab improves patient-reported outcomes among adults with moderate-to-severe atopic dermatitis (AD) in clinical practice: 30-36 month results from the RELIEVE-AD study. Journal of the American Academy of Dermatology. 87(3). AB159–AB159.

10.

Yosipovitch, Gil, Marjolein de Bruin‐Weller, April W. Armstrong, et al.. (2021). Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology and Therapy. 11(6). 2147–2157. 7 indexed citations

11.

Bruin‐Weller, Marjolein de, Joseph F. Merola, Chih-ho Hong, et al.. (2021). Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective. Dermatology and Therapy. 11(6). 2123–2131. 1 indexed citations

12.

Simpson, Eric L., Marjolein de Bruin‐Weller, Ashish Bansal, et al.. (2021). Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis. Dermatology and Therapy. 11(4). 1415–1422. 15 indexed citations

13.

Irvine, Alan D., Mette Deleuran, Amy Praestgaard, et al.. (2021). 27431 Dupilumab treatment improves health-related quality of life in children aged ≥6 to <12 years with severe atopic dermatitis. Journal of the American Academy of Dermatology. 85(3). AB144–AB144. 1 indexed citations

14.

Strober, Bruce, Usha G. Mallya, Min Yang, et al.. (2021). Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis. JAMA Dermatology. 158(2). 142–142. 12 indexed citations

15.

Silverberg, Jonathan I., Eric L. Simpson, Stephan Weidinger, et al.. (2021). Children With Atopic Dermatitis (AD) Have a High Burden of Atopic Comorbidities: Results From a Large Worldwide Survey. Journal of Allergy and Clinical Immunology. 147(2). AB31–AB31. 4 indexed citations

16.

Paller, Amy S., Elaine C. Siegfried, Gil Yosipovitch, et al.. (2021). 27389 Rapid and sustained improvement in itch in children aged 6–11 years with severe atopic dermatitis (AD) treated with dupilumab: Analysis from the LIBERTY AD PEDS phase 3 trial. Journal of the American Academy of Dermatology. 85(3). AB140–AB140. 2 indexed citations

17.

Delevry, Dimittri & Quang A. Le. (2020). PCN55 ECONOMIC ANALYSIS OF COMBINATION THERAPY WITH ALPELISIB AND FULVESTRANT FOR TREATMENT OF HORMONE RECEPTOR-POSITIVE (HR+) AND HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HER2-) ADVANCED BREAST CANCER. Value in Health. 23. S32–S33.

18.

Delevry, Dimittri, et al.. (2020). Association between processes of diabetes care and health care utilization in patients with diabetes: Evidence from a nationally representative US sample. Journal of Diabetes. 13(1). 78–88. 16 indexed citations

19.

Le, Quang A., et al.. (2020). Cost-Effectiveness of Treatment Strategies with Biologics in Accordance with Treatment Guidelines for Ankylosing Spondylitis: A Patient-Level Model. Journal of Managed Care & Specialty Pharmacy. 26(10). 1219–1231. 5 indexed citations

20.

Delevry, Dimittri & Quang A. Le. (2019). Effect of Treatment Preference in Randomized Controlled Trials: Systematic Review of the Literature and Meta-Analysis. Patient. 12(6). 593–609. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact